APVO 13G

Company

Aptevo Therapeutics Inc.

Filed

November 8, 2024

Accession Number

0002033916-24-000031

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →